Comparison of the Genetic Variability of Human Immunodeficiency Virus Type 1 (HIV-1) In Blood Plasma and Cervicovaginal Lavage Using C2v3 Region of the Env Gene
No Thumbnail Available
Date
2003-01
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Ababa University
Abstract
To investigate the characteristics of HIV-1 in the female genital tract and the molecular
epidemiology of subtypes, cell-free viral populations in the blood plasma and vaginal mucosa of
women infected with HIV-1 using DNA sequencing of C2V3 region of the env gene were
examined. Study subjects were those who had visited a sexually transmitted disease clinic for
genital tract inflammation (n = 32 of which 29 had sexually transmitted infections) in Addis
Ababa, Ethiopia. From the study subjects, 28 of the blood plasma and 22 of the cervicovaginal
lavage viruses were successfully amplified and sequenced. 31 of the subjects carried subtype C
and only one subject carried subtype A. Among the total individuals carrying subtype C, 12 and
19 were with subclusters C and C’, respectively.
The sequences in cervicovaginal lavage differed significantly from those in plasma. The number
of nonsynonymous substitutions significantly exceeded synonymous substitutions in both plasma
and cervicovaginal lavage in almost all the study subjects. Sequences from both compartments
within an individual were more closely related to each other than to those obtained from viruses
of other individuals when evaluated through phylogenetic analysis. However, there were
significant genotypic differences between viruses in the two compartments of an individual.
Differences in nucleotide sequences, in net charge of amino acids at physiological pH and
predicted amino acid sequences were also observed. These differences could be due to selective
immune pressures operating in the two compartments, which could lead to differential evolution
of the viruses in vaginal mucosa and plasma that can lead to differential evolution of the viruses.
These findings indicate that cellular replication of HIV-1 occurs in vaginal mucosa that results in
a virus population with important differences from that in blood. This could result in different
resistance patterns in the two compartments in the era of chemotherapies. Thus, resistance
patterns in the viruses derived from the genital mucosa should be taken into account in order to
prevent transmission of resistant viruses through exposure to the genital tract. For vaccine
candidates, viruses derived from the genital compartment should be considered. So far, vaccine
candidates are based on virus isolates from blood only. This indicates a need of considering all
heterogeneity in all compartments to produce effective vaccines and therapies.
Description
Keywords
Biology